Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Hoseok Koo, Inje University
ClinicalTrials.gov Identifier:
NCT01612182
First received: May 29, 2012
Last updated: June 4, 2012
Last verified: June 2012

May 29, 2012
June 4, 2012
March 2012
Not Provided
The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy [ Time Frame: During hospitalization ] [ Designated as safety issue: No ]
The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)
Same as current
Complete list of historical versions of study NCT01612182 on ClinicalTrials.gov Archive Site
The prevalence of ESBL Klebsiella pneumonia in patient with pneumonia and renal replacement therapy [ Time Frame: during hospitalization ] [ Designated as safety issue: No ]
The prevalence of ESBL Klebsiella pneumoina in patient with pneumonia and renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)
Same as current
Not Provided
Not Provided
 
The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy
Not Provided

The prevalence of ESBL Klebsiella pneumonia was higher in patient with renal replacement therapy.

Not Provided
Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

The patients had admitted in single center

End-stage Renal Disease
Other: renal replacement therapy
renal replacement therapy : hemodialysis and/or CRRT(continuous renal replacement therapy )
  • ESBL(+) Klebsiella pneumonia
    All the patient who's the culture result showed ESBL(+) Klebsiella pneumonia in any site during hospitalization
    Intervention: Other: renal replacement therapy
  • ESBL(-) Klebsiella pneumonia
    All the patient who's the culture result showed ESBL(-) Klebsiella pneumonia in any site during hospitalization
    Intervention: Other: renal replacement therapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1289
May 2012
Not Provided

Inclusion Criteria:

  • The age of patient was between 18 yrs and 79 yrs.
  • The patient who showed Klebsiella pneumonia in 1st culture result of any site during hospitalization

Exclusion Criteria:

  • The level of serum albumin was below 2.0 or over 5.0
  • The level of AST or ALT was 2 times of normal level or the level of bilirubin was over 2.0 mg/dL during 1month.
  • The level of Body mass index was below 15 or over 30
  • Pregnancy
Both
18 Years to 79 Years
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
NCT01612182
ESBL 2012-1
Not Provided
Hoseok Koo, Inje University
Inje University
Not Provided
Not Provided
Inje University
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP